Unlicensed pandemic influenza A H1N1 vaccines

The Lancet

Volumn 375, Issue 9713, 2010, Pages 444-445

  Caplan, Arthur L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; DRUG MANUFACTURE; FOOD AND DRUG ADMINISTRATION; IMMUNIZATION; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; PANDEMIC; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

EID: 75749150808     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61675-5     Document Type: Note

References (7)

1. Strategic Advisory Group of Experts on Immunization. Report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic. Wkly Epidemiol Rec 84 (2009) 301-308
2. MSNBC. U.S. to share swine flu vaccine globally (Sept 17, 2009). http://www.msnbc.msn.com/id/32896769/ns/health-swine_flu (accessed Sept 22, 2009).
3. WHO. WHO supports fair access to influenza A (H1N1) vaccine. An interview with Marie-Paule Kieny. Bull World Health Organ 87 (2009) 645-732
4. Collin N., de Radiguès X., and the World Health Organization H1N1 Vaccine Task Force. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 27 (2009) 5184-5186
5. Neuzil K.M., and Bright R.A. Influenza vaccine manufacture: keeping up with change. J Infect Dis 200 (2009) 835-837
6. Nightingale S., Prasher J., and Simonson S. Emergency use authorization (EUA) to enable use of needed products in civilian and military emergencies, United States. Emerg Infect Dis 13 (2007) 1046-1051
7. Lancet. Supply and safety issues surrounding an H1N1 vaccine. Lancet 374 (2009) 358